Journal of Korean Neurosurgical Society

  • 제65권3호
  • /
  • Pages.439-448
  • /
  • 2022
  • /
  • 2005-3711(pISSN)
  • /
  • 1598-7876(eISSN)
대한신경외과학회 (The Korean Neurosurgical Society)
권호 표지
DOI QR코드

DOI QR Code

Determinants of Short-Term Weight Gain Following Surgical Treatment for Craniopharyngioma in Adults

  • Hong, A Ram (Department of Internal Medicine, Chonnam National University Medical School) ;
  • Kim, Jung Hee (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Park, Seung Shin (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Kong, Sung Hye (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Choi, Hyung Jin (Department of Anatomy, Seoul National University College of Medicine) ;
  • Kim, Yong Hwy (Department of Pituitary Center, Seoul National University College of Medicine) ;
  • Shin, Chan Soo (Department of Internal Medicine, Seoul National University College of Medicine)
  • 투고 : 2021.03.16
  • 심사 : 2021.08.12
  • 발행 : 2022.05.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective : Craniopharyngiomas (CPs) are associated with hypothalamic damage that causes hypothalamic obesity, however, the mechanisms underlying CP-related postoperative weight gain remain debatable. This study aimed to elucidate whether the major determinant of postoperative weight gain in patients with CP is hypothalamic injury or steroid replacement therapy. Methods : We included 48 adult patients with CP (age ≥18 years) who underwent transsphenoidal surgery between 2010 and 2018 in a single tertiary center, and whose body weight was measured pre- and postoperatively (<120 days after the surgery). We recruited 144 age- and body mass index-matched patients with non-functioning pituitary adenoma (NFPA) as controls. Results : Patients with CP experienced greater postoperative weight gain than patients with NFPA (3.0±5.1 vs. 0.1±3.6 kg, p<0.001). The prevalence of postoperative steroid use was significantly higher in patients with CP than in those with NFPA (89.6% vs. 34.0%, p<0.001). Steroid replacement therapy and CP were associated with postoperative weight gain after adjusting for covariates in overall patients (p=0.032 and 0.007, respectively). In subgroup analysis with postoperative steroid users, weight gain was significantly greater in patients with CP (n=43, 0.96±0.25 kg/month) than in patients with NFPA (n=49, 0.26±0.23 kg/month) even after adjusting for the daily steroid dose (p=0.048). Conclusion : Patients with CP experience greater postoperative weight gain than those with NFPA. Hypothalamic damage itself as well as steroid replacement may contribute to the postoperative weight gain in patients with CP.

키워드

참고문헌

  1. Bomer I, Saure C, Caminiti C, Ramos JG, Zuccaro G, Brea M, et al. : Comparison of energy expenditure, body composition, metabolic disorders, and energy intake between obese children with a history of craniopharyngioma and children with multifactorial obesity. J Pediatr Endocrinol Metab 28 : 1305-1312, 2015
  2. Buchfelder M, Schlaffer SM, Lin F, Kleindienst A : Surgery for craniopharyngioma. Pituitary 16 : 18-25, 2013 https://doi.org/10.1007/s11102-012-0414-8
  3. Cohen M, Guger S, Hamilton J : Long term sequelae of pediatric craniopharyngioma - literature review and 20 years of experience. Front Endocrinol (Lausanne) 2 : 81, 2011 https://doi.org/10.3389/fendo.2011.00081
  4. Dho YS, Kim YH, Se YB, Han DH, Kim JH, Park CK, et al. : Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor. J Neurosurg 129 : 611-619, 2018 https://doi.org/10.3171/2017.4.jns162143
  5. Erfurth EM, Holmer H, Fjalldal SB : Mortality and morbidity in adult craniopharyngioma. Pituitary 16 : 46-55, 2013 https://doi.org/10.1007/s11102-012-0428-2
  6. Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M : Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90 : 237-250, 1999 https://doi.org/10.3171/jns.1999.90.2.0237
  7. Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, et al. : Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101 : 3888-3921, 2016 https://doi.org/10.1210/jc.2016-2118
  8. Harz KJ, Muller HL, Waldeck E, Pudel V, Roth C : Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab 88 : 5227-5231, 2003 https://doi.org/10.1210/jc.2002-021797
  9. Karavitaki N, Brufani C, Warner JT, Adams CB, Richards P, Ansorge O, et al. : Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62 : 397-409, 2005 https://doi.org/10.1111/j.1365-2265.2005.02231.x
  10. Lee M, Korner J : Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans. Pituitary 12 : 87-95, 2009 https://doi.org/10.1007/s11102-008-0096-4
  11. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW : Central nervous system control of food intake and body weight. Nature 443 : 289-295, 2006 https://doi.org/10.1038/nature05026
  12. Muller HL : Craniopharyngioma. Endocr Rev 35 : 513-543, 2014 https://doi.org/10.1210/er.2013-1115
  13. Muller HL, Handwerker G, Wollny B, Faldum A, Sorensen N : Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab 87 : 3993-3996, 2002 https://doi.org/10.1210/jc.87.8.3993
  14. Muller HL, Heinrich M, Bueb K, Etavard-Gorris N, Gebhardt U, Kolb R, et al. : Perioperative dexamethasone treatment in childhood craniopharyngioma--influence on short-term and long-term weight gain. Exp Clin Endocrinol Diabetes 111 : 330-334, 2003 https://doi.org/10.1055/s-2003-42722
  15. Ni W, Shi X : Interventions for the treatment of craniopharyngiomarelated hypothalamic obesity: a systematic review. World Neurosurg 118 : e59-e71, 2018 https://doi.org/10.1016/j.wneu.2018.06.121
  16. Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, et al. : Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 106(1 Suppl) : 3-12, 2007
  17. Roth CL : Hypothalamic obesity in craniopharyngioma patients: disturbed energy homeostasis related to extent of hypothalamic damage and its implication for obesity intervention. J Clin Med 4 : 1774-1797, 2015 https://doi.org/10.3390/jcm4091774
  18. Roth CL, Eslamy H, Werny D, Elfers C, Shaffer ML, Pihoker C, et al. : Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity. Obesity (Silver Spring) 23 : 1226-1233, 2015 https://doi.org/10.1002/oby.21067
  19. Seong J, Kang JY, Sun JS, Kim KW : Hypothalamic inflammation and obesity: a mechanistic review. Arch Pharm Res 42 : 383-392, 2019 https://doi.org/10.1007/s12272-019-01138-9
  20. Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbuchel AM, Muller HL : Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro Oncol 17 : 1029-1038, 2015 https://doi.org/10.1093/neuonc/nov044
  21. van Swieten MM, Pandit R, Adan RA, van der Plasse G : The neuroanatomical function of leptin in the hypothalamus. J Chem Neuroanat 61-62 : 207-220, 2014 https://doi.org/10.1016/j.jchemneu.2014.05.004
  22. Wijnen M, van den Heuvel-Eibrink MM, Janssen JAMJL, CatsmanBerrevoets CE, Michiels EMC, van Veelen-Vincent MC, et al. : Very longterm sequelae of craniopharyngioma. Eur J Endocrinol 176 : 755-767, 2017 https://doi.org/10.1530/EJE-17-0044
  23. World Health Organization : The Asia-Pacific perspective: redefining obesity and its treatment. Available at : https://apps.who.int/iris/bitstream/handle/10665/206936/0957708211_eng.pdf